Research Article
The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China
Table 2
RIF resistance determined by GeneXpert.
| | | RIF resistance determined by GeneXpert (%) | | Resistant | Susceptible | Indeterminate | Total |
| | Sputum | 1 (4.8) | 19 (90.4) | 1 (4.8) | 21 (100.0) | | GLA | 4 (6.1) | 59 (90.8) | 2 (3.1) | 65 (100.0) | | BALF | 2 (5.4) | 33 (89.2) | 2 (5.4) | 37 (100.0) | | CSF | 2 (12.5) | 10 (62.5) | 4 (25.0) | 16 (100.0) | | Total | 9 (6.5) | 121 (87.0) | 9 (6.5) | 139 (100.0) |
|
|
GLA, gastric lavage aspirate; BALF, bronchoalveolar lavage fluid; CSF, cerebrospinal fluid.
|
